Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

Katrine Baumann; Astrid-Helene Ravn Jørgensen; Jennifer Astrup Sørensen; Ditte Georgina Zhang; Misbah Noshela Ghazanfar; Per Stahl Skov; Anders Woetmann; Christian Vestergaard; Marcus Maurer; Simon Francis Thomsen

doi:10.1111/cea.14402

Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

Katrine Baumann, Astrid-Helene Ravn Jørgensen, Jennifer Astrup Sørensen, Ditte Georgina Zhang, Misbah Noshela Ghazanfar, Per Stahl Skov, Anders Woetmann, Christian Vestergaard, Marcus Maurer, Simon Francis Thomsen

Dermato- & Venerologisk Afd.

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Vol/bind	53
Udgave nummer	12
Sider (fra-til)	1318-1321
Antal sider	4
ISSN	0954-7894
DOI	https://doi.org/10.1111/cea.14402
Status	Udgivet - dec. 2023

Adgang til dokumentet

10.1111/cea.14402

Andre filer og links

Link to publication in Scopus

Citationsformater

Baumann, K., Jørgensen, A.-H. R., Sørensen, J. A., Zhang, D. G., Ghazanfar, M. N., Skov, P. S., Woetmann, A., Vestergaard, C., Maurer, M., & Thomsen, S. F. (2023). Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 53(12), 1318-1321. https://doi.org/10.1111/cea.14402

Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria. / Baumann, Katrine; Jørgensen, Astrid-Helene Ravn; Sørensen, Jennifer Astrup et al.
I: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, Bind 53, Nr. 12, 12.2023, s. 1318-1321.

Publikation: Bidrag til tidsskrift › Letter › peer review

Baumann, K, Jørgensen, A-HR, Sørensen, JA, Zhang, DG, Ghazanfar, MN, Skov, PS, Woetmann, A, Vestergaard, C, Maurer, M & Thomsen, SF 2023, 'Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria', Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, bind 53, nr. 12, s. 1318-1321. https://doi.org/10.1111/cea.14402

Baumann K, Jørgensen AHR, Sørensen JA, Zhang DG, Ghazanfar MN, Skov PS et al. Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2023 dec.;53(12):1318-1321. doi: 10.1111/cea.14402

Baumann, Katrine ; Jørgensen, Astrid-Helene Ravn ; Sørensen, Jennifer Astrup et al. / Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria. I: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2023 ; Bind 53, Nr. 12. s. 1318-1321.

@article{b2eed075139e4084a9138556e5748130,

title = "Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria",

keywords = "Humans, Omalizumab/therapeutic use, Basophils, Histamine Release, Chronic Urticaria/drug therapy, Anti-Allergic Agents/therapeutic use, Chronic Disease, Urticaria/diagnosis",

author = "Katrine Baumann and J{\o}rgensen, {Astrid-Helene Ravn} and S{\o}rensen, {Jennifer Astrup} and Zhang, {Ditte Georgina} and Ghazanfar, {Misbah Noshela} and Skov, {Per Stahl} and Anders Woetmann and Christian Vestergaard and Marcus Maurer and Thomsen, {Simon Francis}",

year = "2023",

month = dec,

doi = "10.1111/cea.14402",

language = "English",

volume = "53",

pages = "1318--1321",

journal = "Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

TY - JOUR

T1 - Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

AU - Baumann, Katrine

AU - Jørgensen, Astrid-Helene Ravn

AU - Sørensen, Jennifer Astrup

AU - Zhang, Ditte Georgina

AU - Ghazanfar, Misbah Noshela

AU - Skov, Per Stahl

AU - Woetmann, Anders

AU - Vestergaard, Christian

AU - Maurer, Marcus

AU - Thomsen, Simon Francis

PY - 2023/12

Y1 - 2023/12

KW - Humans

KW - Omalizumab/therapeutic use

KW - Basophils

KW - Histamine Release

KW - Chronic Urticaria/drug therapy

KW - Anti-Allergic Agents/therapeutic use

KW - Chronic Disease

KW - Urticaria/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85173983055&partnerID=8YFLogxK

U2 - 10.1111/cea.14402

DO - 10.1111/cea.14402

M3 - Letter

C2 - 37771063

SN - 0954-7894

VL - 53

SP - 1318

EP - 1321

JO - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

JF - Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

IS - 12

ER -